Global Anti-Emetic Drug Market Research Report 2021

1 Anti-Emetic Drug Market Overview

• 1.1 Product Overview and Scope of Anti-Emetic Drug
• 1.2 Anti-Emetic Drug Segment by Type
  • 1.2.1 Global Anti-Emetic Drug Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Oral
  • 1.2.3 Injection
  • 1.2.4 Others
• 1.3 Anti-Emetic Drug Segment by Application
  • 1.3.1 Anti-Emetic Drug Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Home Care
  • 1.3.5 Others
• 1.4 Global Anti-Emetic Drug Market Size Estimates and Forecasts
  • 1.4.1 Global Anti-Emetic Drug Revenue 2016-2027
  • 1.4.2 Global Anti-Emetic Drug Sales 2016-2027
  • 1.4.3 Anti-Emetic Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Anti-Emetic Drug Market Competition by Manufacturers

• 2.1 Global Anti-Emetic Drug Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Anti-Emetic Drug Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Anti-Emetic Drug Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Anti-Emetic Drug Manufacturing Sites, Area Served, Product Type
• 2.5 Anti-Emetic Drug Market Competitive Situation and Trends
  • 2.5.1 Anti-Emetic Drug Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Anti-Emetic Drug Players Market Share by Revenue
  • 2.5.3 Global Anti-Emetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anti-Emetic Drug Retrospective Market Scenario by Region

• 3.1 Global Anti-Emetic Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Anti-Emetic Drug Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Anti-Emetic Drug Market Facts & Figures by Country
  • 3.3.1 North America Anti-Emetic Drug Sales by Country
  • 3.3.2 North America Anti-Emetic Drug Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Anti-Emetic Drug Market Facts & Figures by Country
  • 3.4.1 Europe Anti-Emetic Drug Sales by Country
  • 3.4.2 Europe Anti-Emetic Drug Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Anti-Emetic Drug Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Anti-Emetic Drug Sales by Region
  • 3.5.2 Asia Pacific Anti-Emetic Drug Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Anti-Emetic Drug Market Facts & Figures by Country
  • 3.6.1 Latin America Anti-Emetic Drug Sales by Country
  • 3.6.2 Latin America Anti-Emetic Drug Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Anti-Emetic Drug Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Anti-Emetic Drug Sales by Country
  • 3.7.2 Middle East and Africa Anti-Emetic Drug Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Anti-Emetic Drug Historic Market Analysis by Type

• 4.1 Global Anti-Emetic Drug Sales Market Share by Type (2016-2021)
• 4.2 Global Anti-Emetic Drug Revenue Market Share by Type (2016-2021)
• 4.3 Global Anti-Emetic Drug Price by Type (2016-2021)

5 Global Anti-Emetic Drug Historic Market Analysis by Application

• 5.1 Global Anti-Emetic Drug Sales Market Share by Application (2016-2021)
• 5.2 Global Anti-Emetic Drug Revenue Market Share by Application (2016-2021)
• 5.3 Global Anti-Emetic Drug Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Merck
  • 6.1.1 Merck Corporation Information
  • 6.1.2 Merck Description and Business Overview
  • 6.1.3 Merck Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Merck Product Portfolio
  • 6.1.5 Merck Recent Developments/Updates
• 6.2 Novartis
  • 6.2.1 Novartis Corporation Information
  • 6.2.2 Novartis Description and Business Overview
  • 6.2.3 Novartis Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Novartis Product Portfolio
  • 6.2.5 Novartis Recent Developments/Updates
• 6.3 Glenmark Pharmaceuticals
  • 6.3.1 Glenmark Pharmaceuticals Corporation Information
  • 6.3.2 Glenmark Pharmaceuticals Description and Business Overview
  • 6.3.3 Glenmark Pharmaceuticals Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Glenmark Pharmaceuticals Product Portfolio
  • 6.3.5 Glenmark Pharmaceuticals Recent Developments/Updates
• 6.4 F. Hoffmann-La Roche
  • 6.4.1 F. Hoffmann-La Roche Corporation Information
  • 6.4.2 F. Hoffmann-La Roche Description and Business Overview
  • 6.4.3 F. Hoffmann-La Roche Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 F. Hoffmann-La Roche Product Portfolio
  • 6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
• 6.5 Heron Therapeutics
  • 6.5.1 Heron Therapeutics Corporation Information
  • 6.5.2 Heron Therapeutics Description and Business Overview
  • 6.5.3 Heron Therapeutics Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Heron Therapeutics Product Portfolio
  • 6.5.5 Heron Therapeutics Recent Developments/Updates
• 6.6 Kyowa Kirin
  • 6.6.1 Kyowa Kirin Corporation Information
  • 6.6.2 Kyowa Kirin Description and Business Overview
  • 6.6.3 Kyowa Kirin Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Kyowa Kirin Product Portfolio
  • 6.6.5 Kyowa Kirin Recent Developments/Updates
• 6.7 Aurobindo Pharma
  • 6.6.1 Aurobindo Pharma Corporation Information
  • 6.6.2 Aurobindo Pharma Description and Business Overview
  • 6.6.3 Aurobindo Pharma Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Aurobindo Pharma Product Portfolio
  • 6.7.5 Aurobindo Pharma Recent Developments/Updates
• 6.8 Mylan
  • 6.8.1 Mylan Corporation Information
  • 6.8.2 Mylan Description and Business Overview
  • 6.8.3 Mylan Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Mylan Product Portfolio
  • 6.8.5 Mylan Recent Developments/Updates
• 6.9 Hikma
  • 6.9.1 Hikma Corporation Information
  • 6.9.2 Hikma Description and Business Overview
  • 6.9.3 Hikma Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Hikma Product Portfolio
  • 6.9.5 Hikma Recent Developments/Updates
• 6.10 Akorn
  • 6.10.1 Akorn Corporation Information
  • 6.10.2 Akorn Description and Business Overview
  • 6.10.3 Akorn Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Akorn Product Portfolio
  • 6.10.5 Akorn Recent Developments/Updates
• 6.11 Dr. Reddy’s Laboratories
  • 6.11.1 Dr. Reddy’s Laboratories Corporation Information
  • 6.11.2 Dr. Reddy’s Laboratories Anti-Emetic Drug Description and Business Overview
  • 6.11.3 Dr. Reddy’s Laboratories Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Dr. Reddy’s Laboratories Product Portfolio
  • 6.11.5 Dr. Reddy’s Laboratories Recent Developments/Updates
• 6.12 Cipla
  • 6.12.1 Cipla Corporation Information
  • 6.12.2 Cipla Anti-Emetic Drug Description and Business Overview
  • 6.12.3 Cipla Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Cipla Product Portfolio
  • 6.12.5 Cipla Recent Developments/Updates
• 6.13 Fresenius Kabi
  • 6.13.1 Fresenius Kabi Corporation Information
  • 6.13.2 Fresenius Kabi Anti-Emetic Drug Description and Business Overview
  • 6.13.3 Fresenius Kabi Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Fresenius Kabi Product Portfolio
  • 6.13.5 Fresenius Kabi Recent Developments/Updates
• 6.14 Wockhardt
  • 6.14.1 Wockhardt Corporation Information
  • 6.14.2 Wockhardt Anti-Emetic Drug Description and Business Overview
  • 6.14.3 Wockhardt Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Wockhardt Product Portfolio
  • 6.14.5 Wockhardt Recent Developments/Updates
• 6.15 Sun Pharmaceutical Industries
  • 6.15.1 Sun Pharmaceutical Industries Corporation Information
  • 6.15.2 Sun Pharmaceutical Industries Anti-Emetic Drug Description and Business Overview
  • 6.15.3 Sun Pharmaceutical Industries Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Sun Pharmaceutical Industries Product Portfolio
  • 6.15.5 Sun Pharmaceutical Industries Recent Developments/Updates
• 6.16 Teva Pharmaceutical
  • 6.16.1 Teva Pharmaceutical Corporation Information
  • 6.16.2 Teva Pharmaceutical Anti-Emetic Drug Description and Business Overview
  • 6.16.3 Teva Pharmaceutical Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Teva Pharmaceutical Product Portfolio
  • 6.16.5 Teva Pharmaceutical Recent Developments/Updates
• 6.17 Pfizer
  • 6.17.1 Pfizer Corporation Information
  • 6.17.2 Pfizer Anti-Emetic Drug Description and Business Overview
  • 6.17.3 Pfizer Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Pfizer Product Portfolio
  • 6.17.5 Pfizer Recent Developments/Updates

7 Anti-Emetic Drug Manufacturing Cost Analysis

• 7.1 Anti-Emetic Drug Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Anti-Emetic Drug
• 7.4 Anti-Emetic Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Anti-Emetic Drug Distributors List
• 8.3 Anti-Emetic Drug Customers

9 Anti-Emetic Drug Market Dynamics

• 9.1 Anti-Emetic Drug Industry Trends
• 9.2 Anti-Emetic Drug Growth Drivers
• 9.3 Anti-Emetic Drug Market Challenges
• 9.4 Anti-Emetic Drug Market Restraints

10 Global Market Forecast

• 10.1 Anti-Emetic Drug Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Anti-Emetic Drug by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Anti-Emetic Drug by Type (2022-2027)
• 10.2 Anti-Emetic Drug Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Anti-Emetic Drug by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Anti-Emetic Drug by Application (2022-2027)
• 10.3 Anti-Emetic Drug Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Anti-Emetic Drug by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Anti-Emetic Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List